These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37238911)

  • 21. Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor.
    Mizukami A; Thomé CH; Ferreira GA; Lanfredi GP; Covas DT; Pitteri SJ; Swiech K; Faça VM
    Front Bioeng Biotechnol; 2019; 7():154. PubMed ID: 31297369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia Pre-Conditioned Embryonic Mesenchymal Stem Cell Secretome Reduces IL-10 Production by Peripheral Blood Mononuclear Cells.
    Lotfinia M; Lak S; Mohammadi Ghahhari N; Johari B; Maghsood F; Parsania S; Sadegh Tabrizi B; Kadivar M
    Iran Biomed J; 2017 Jan; 21(1):24-31. PubMed ID: 27132108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-α-synuclein Toxicity and Anti-neurodegenerative Role of Chrysin in Transgenic
    Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
    ACS Chem Neurosci; 2022 Feb; 13(4):442-453. PubMed ID: 35118868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutathione
    Jewett M; Dickson E; Brolin K; Negrini M; Jimenez-Ferrer I; Swanberg M
    Front Neurol; 2018; 9():222. PubMed ID: 29681884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease.
    Bahat-Stroomza M; Barhum Y; Levy YS; Karpov O; Bulvik S; Melamed E; Offen D
    J Mol Neurosci; 2009 Sep; 39(1-2):199-210. PubMed ID: 19127447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease.
    d'Angelo M; Cimini A; Castelli V
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An In Vitro Partial Lesion Model of Differentiated Human Mesencephalic Neurons: Effect of Pericyte Secretome on Phenotypic Markers.
    Gaceb A; Barbariga M; Paul G
    J Mol Neurosci; 2020 Nov; 70(11):1914-1925. PubMed ID: 32472394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
    Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
    FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploiting the impact of the secretome of MSCs isolated from different tissue sources on neuronal differentiation and axonal growth.
    Assunção-Silva RC; Mendes-Pinheiro B; Patrício P; Behie LA; Teixeira FG; Pinto L; Salgado AJ
    Biochimie; 2018 Dec; 155():83-91. PubMed ID: 30077816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson's Disease.
    Tsai CW; Tsai RT; Liu SP; Chen CS; Tsai MC; Chien SH; Hung HS; Lin SZ; Shyu WC; Fu RH
    Cell Transplant; 2017 Dec; 26(12):1903-1918. PubMed ID: 29390878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.
    Harrell CR; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
    Cells; 2019 May; 8(5):. PubMed ID: 31100966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
    Ahlers-Dannen KE; Spicer MM; Fisher RA
    Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in cytokines and neurotrophins in Parkinson's disease.
    Nagatsu T; Mogi M; Ichinose H; Togari A
    J Neural Transm Suppl; 2000; (60):277-90. PubMed ID: 11205147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A xeno-free microcarrier-based stirred culture system for the scalable expansion of human mesenchymal stem/stromal cells isolated from bone marrow and adipose tissue.
    Carmelo JG; Fernandes-Platzgummer A; Diogo MM; da Silva CL; Cabral JM
    Biotechnol J; 2015 Aug; 10(8):1235-47. PubMed ID: 26136376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients.
    Chadid T; Morris A; Surowiec A; Robinson S; Sasaki M; Galipeau J; Pollack BP; Brewster LP
    J Vasc Surg; 2018 Dec; 68(6S):137S-151S.e2. PubMed ID: 30104096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of matrix metalloproteinase 3-mediated alpha-synuclein cleavage in dopaminergic cell death.
    Choi DH; Kim YJ; Kim YG; Joh TH; Beal MF; Kim YS
    J Biol Chem; 2011 Apr; 286(16):14168-77. PubMed ID: 21330369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of cannabidiol on dopaminergic neurodegeneration and α-synuclein accumulation in C. elegans models of Parkinson's disease.
    Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
    Neurotoxicology; 2022 Dec; 93():128-139. PubMed ID: 36108815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dental Mesenchymal Stem Cell Secretome: An Intriguing Approach for Neuroprotection and Neuroregeneration.
    Gugliandolo A; Mazzon E
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.